CUE (Cue Biopharma) Insider Ownership: 75.06 % (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CUE Cue Biopharma Inc CUE
42 GF Score
Price $23.18
! 3 Warning Signs
View Full Analysis

What is Cue Biopharma Insider Ownership?

Cue Biopharma CUE -3.34% 42 Insider Ownership is 75.06 % as of Aug. 24, 2026. GuruFocus rates CUE with a GF Score™ of 42/100. The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cue Biopharma's insider ownership is 75.06%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cue Biopharma's Institutional Ownership is 13.01%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cue Biopharma's Float Percentage Of Total Shares Outstanding is 95.30%.

Cue Biopharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for Cue Biopharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cue Biopharma Insider Ownership Chart

Cue Biopharma Historical Data

The historical data trend for Cue Biopharma can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 2.94 2.89 2.89 2.89 2.82 2.79 2.79 70.93 69.62 75.06
CUE
42GF Score
Cue Biopharma Inc CUE
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cue Biopharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 75.06 % mean?
Cue Biopharma (CUE) has a Insider Ownership of 75.06 % as of Aug. 24, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Cue Biopharma and its competitors.
Is Cue Biopharma's Insider Ownership too high?
Cue Biopharma's current Insider Ownership is 75.06 %. Overall, Cue Biopharma has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Cue Biopharma's Insider Ownership compare to CNTB and CDXS?
Cue Biopharma's Insider Ownership of 75.06 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Cue Biopharma and its competitors. Cue Biopharma's current Insider Ownership is 75.06 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cue Biopharma stock overvalued right now?
Cue Biopharma (CUE) has a current Insider Ownership of 75.06 %. The current Insider Ownership is 75.06 %. Cue Biopharma's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Cue Biopharma (CUE), the current Insider Ownership is 75.06 % as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cue Biopharma Business Description

Other Exchanges 1UC0:Germany
Address 40 Guest Street, Boston, MA, USA, 02135
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
42GF Score

Get the complete analysis for CUE

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.18
Price